MMA Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MMA Asset Management's XBI Position: Q1 2026 in Review
MMA Asset Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 2,502 shares worth $320K. The stake represents 0.11% of the portfolio and ranks #155 among its holdings. This is a return to the name: MMA Asset Management previously reported a position in XBI as recently as Q3 2025.
MMA Asset Management first reported a position in XBI in Q4 2020 and has held it in 4 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- MMA Asset Management held 2,502 shares of State Street SPDR S&P Biotech ETF worth $320K as of Q1 2026.
- State Street SPDR S&P Biotech ETF was a new MMA Asset Management position in Q1 2026.
- State Street SPDR S&P Biotech ETF made up 0.11% of MMA Asset Management's portfolio in Q1 2026, its #155 holding.
- MMA Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 4 quarters since.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on MMA Asset Management's 13F filing for Q1 2026, filed 8 Apr 2026.